- testing |
₹14,227
(435.2)
(3.15%)
03 Feb , 2026 | 04:14 PM
Open
₹14,367.4
Prev. Close
₹13,791.8
Market Cap.
₹18,49,165.69
Div Yield
0.57
PE
35.49
PB
35.49
₹14,127.2
₹14,400.45
Performance
One Week (%)
-1.14
One Month (%)
-6.34
One Year (%)
-0.07
YTD (%)
2.35
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 26,880 | 27,910 | 26,800 | 10,469 |
Cipla Ltd | 1,322.8 | 1,381.3 | 1,319.6 | 27,11,571 |
Apollo Hospitals Enterprise Ltd | 7,088.5 | 7,163.5 | 7,002.5 | 4,38,009 |
Dr Reddys Laboratories Ltd | 1,235.4 | 1,265.9 | 1,218.1 | 15,21,425 |
Lupin Ltd | 2,185.9 | 2,225 | 2,163.7 | 12,52,989 |
Torrent Pharmaceuticals Ltd | 4,045.6 | 4,104.1 | 4,010.2 | 4,64,524 |
Ipca Laboratories Ltd | 1,435.3 | 1,470 | 1,423.8 | 2,07,460 |
Sun Pharmaceutical Industries Ltd | 1,702.1 | 1,725 | 1,671 | 85,20,586 |
Aurobindo Pharma Ltd | 1,226.1 | 1,247.3 | 1,211.2 | 28,27,489 |
Biocon Ltd | 372.3 | 387.7 | 370.9 | 48,40,490 |
Alkem Laboratories Ltd | 5,702.5 | 5,747 | 5,628 | 1,75,751 |
Glenmark Pharmaceuticals Ltd | 1,954.2 | 2,006.6 | 1,947.6 | 5,35,670 |
Zydus Lifesciences Ltd | 902.9 | 916.85 | 895.25 | 10,50,230 |
Divis Laboratories Ltd | 6,209 | 6,304.5 | 6,150 | 4,54,227 |
Max Healthcare Institute Ltd | 1,003.5 | 1,011.05 | 964.7 | 45,28,070 |
Fortis Healthcare Ltd | 863.1 | 870.95 | 852.15 | 19,95,886 |
Syngene International Ltd | 478 | 512.95 | 474.55 | 19,91,438 |
Mankind Pharma Ltd | 2,162.6 | 2,190.2 | 2,112.3 | 7,78,709 |
Laurus Labs Ltd | 975.6 | 1,020 | 969.9 | 19,22,427 |
Piramal Pharma Ltd | 161.23 | 166.56 | 160.02 | 38,31,082 |
Sector-wise, the Metal index emerged as a standout performer, witnessing a substantial 4% surge.
1 Mar 2024|03:40 PM
This revision applies to all Bank Nifty contracts, including weekly, monthly, and quarterly, shifting their expiry to Wednesdays
1 Mar 2024|09:57 AM
Bharat Highways InvIT, which boasts a portfolio of seven road assets, launched the IPO with the goal of raising ₹2,500 Crore
29 Feb 2024|11:42 AM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
